Simacas, Miguela C.
HRN: 11-06-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/17/2023
01/23/2023
IV
500 Mg
Q 8 Hours
Cap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes